Atovaquone
NDC 17856-0631, Atovaquone, suspension, from ATLANTIC BIOLOGICALS CORP..
- Product NDC
- 17856-0631
- Status
- Listed
- Labeler
- ATLANTIC BIOLOGICALS CORP.
- Dosage form
- SUSPENSION
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA210692
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/17856-0631 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ATOVAQUONE750 mg/5mL
Pharmacologic classes
Antimalarial [EPC]; Antiprotozoal [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 17856-0631-1 | 17856063101 | 72 CUP, UNIT-DOSE in 1 BOX, UNIT-DOSE (17856-0631-1) / 5 mL in 1 CUP, UNIT-DOSE (17856-0631-2) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/f99a8a0c-2b42-4da0-8f5a-e963fc619e8b
Use it
Look up 17856-0631 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/17856-0631 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 17856-0631. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.